Medication info

Lite Alendronate Tablet 70 mg (Sodium Alendronate Hydrate)

Prescription medicationTabletOralExpired
Ingredient · strength
Sodium Alendronate Hydrate›91.37mg / 1 tablet
Manufacturer / importer
Lite Pharmtech Co., Ltd.
Appearance
White oval-shaped tablet
Packaging
4 tablets / blister
Approval status
Expired

MFDS item code 201902246 · Approved 2019.04.12

This product's status changed to Expired on 2024.04.12. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults
Adult dose
○ Take 70 mg of alendronic acid once weekly in the morning with plenty of water at least 30 minutes before consuming food, beverages, or other medicines (see General Precautions). ○ Other beverages, including mineral water and barley tea, as well as food and medicines, may reduce the absorption of this medicine (see Interactions). If food is consumed within 30 minutes after taking this medicine or at the same time, absorption of the medicine may be reduced, decreasing its effect. Take this medicine immediately after getting up in the morning and swallow it with plenty of water (170 ∼ 230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it and until after the first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and General Precautions). If the patient's intake of calcium and vitamin D from food is insufficient, supplements should be taken (see General Precautions). ○ The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. For patients at low risk of fracture, discontinuation should be considered after 3 ∼ 5 years of treatment. Patients who discontinue treatment should be regularly reassessed for fracture risk. ○ If you forget to take a dose on the scheduled day, take 70 mg the next morning, then resume taking it on the originally scheduled day and continue once weekly thereafter. Do not take 2 tablets on the same day.

Ingredients

Manufacturer
Lite Pharmtech Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

This medication is used for the treatment of osteoporosis in both postmenopausal women and men.

How to take

Adult dose

○ Take 70 mg of alendronic acid once weekly in the morning with plenty of water at least 30 minutes before consuming food, beverages, or other medicines (see General Precautions). ○ Other beverages, including mineral water and barley tea, as well as food and medicines, may reduce the absorption of this medicine (see Interactions). If food is consumed within 30 minutes after taking this medicine or at the same time, absorption of the medicine may be reduced, decreasing its effect. Take this medicine immediately after getting up in the morning and swallow it with plenty of water (170 ∼ 230 mL) to help the medicine reach the stomach quickly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking it and until after the first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and General Precautions). If the patient's intake of calcium and vitamin D from food is insufficient, supplements should be taken (see General Precautions). ○ The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. For patients at low risk of fracture, discontinuation should be considered after 3 ∼ 5 years of treatment. Patients who discontinue treatment should be regularly reassessed for fracture risk. ○ If you forget to take a dose on the scheduled day, take 70 mg the next morning, then resume taking it on the originally scheduled day and continue once weekly thereafter. Do not take 2 tablets on the same day.

Precautions

This medication may irritate the gastric and esophageal mucosa, and caution is required for patients with existing esophageal diseases, gastritis, duodenitis, ulcers, etc. If symptoms such as difficulty swallowing, pain behind the breastbone, or heartburn occur after taking, discontinue immediately and consult a doctor. It is important to take this medication with a sufficient amount of water and not to lie down for at least 30 minutes after taking. Continuing to take this medication after experiencing esophageal irritation symptoms increases the risk of severe esophageal damage. This medication should not be administered to patients with specific esophageal diseases, those unable to sit or stand, patients with hypocalcemia, severe renal failure, pregnant or breastfeeding women, or those with certain genetic diseases. During treatment, side effects such as gastrointestinal disorders, muscle or joint pain, headache, dizziness may occur, and if severe, a doctor should be notified. This medication can interfere with the absorption when taken with calcium supplements or antacids, so a minimum interval of 30 minutes should be maintained. Pregnant women should not take this medication, and breastfeeding women are also advised to avoid it. Safety in children and adolescents under 18 has not been established, so use is not recommended. Elderly patients can take this medication, but some elderly patients may be more sensitive to the drug, so caution is needed. Always follow the doctor's instructions regarding the correct dosage and administration, and it is important to manage calcium and vitamin D intake appropriately before and after taking the medication. Rare side effects such as osteonecrosis of the jaw have also been reported, so consult a doctor if dental treatment is needed. In case of overdose, hypocalcemia and gastrointestinal disorders may occur, so contact a medical institution immediately, and avoid inducing vomiting while keeping the patient in an upright position. Store this medication out of reach of children and do not transfer it to another container for safety.

Side effects

Upper gastrointestinal mucosal irritation, bleeding, esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, dysphagia, odynophagia, retrosternal pain, heartburn, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, vomiting, abdominal distension, gastritis, gastric ulcer, musculoskeletal pain, muscle cramps, headache, dizziness, dysgeusia, rash, erythema, anastomotic ulcer, urticaria, angioedema, myalgia, fatigue, asthenia, fever, symptoms of hypocalcemia, peripheral edema, esophageal stricture, oropharyngeal ulcer, duodenal ulcer, localized jaw osteonecrosis, joint swelling, low-energy fractures of the femoral neck and other bones, dizziness, pruritus, hair loss, mucocutaneous syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, external auditory canal cholesteatoma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture. It is best to maintain a storage temperature between 1°C and 30°C at room temperature.

Appearance and packaging

Appearance

White oval-shaped tablet

Package unit

4 tablets / blister

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.